Global Gastric Cancer Market Growth Analysis and 2021 Forecasts

Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and spread throughout the body. Gastric cancer is when such a condition occurs in the stomach and has the tendency to grow through the wall of the stomach to invade nearby organs including lymph nodes and lymph vessels. There are four types of cancers of the stomach namely, Adenocarcinoma, Lymphoma, Gastrointestinal stromal tumor (GIST), Carcinoid tumor and others such as squamous cell carcinoma, small cell carcinoma, and leiomyosarcomat that can start in the stomach, but are very rare.

Order a copy of this research report at

The causes of stomach cancer are rather unclear in medical study; however, there is a strong correlation between a diet high in smoked, salted and pickled foods, obesity and ageing. People with Helicobacter infections are also highly prone to gastric cancer. Symptoms of gastric cancer may include, fatigue, feeling bloated after eating, severe heartburn and indigestion, stomach pain, persistent and unexplained vomiting and nausea, unintentional weight loss, belching, anemia, and persistent ulcer. Its medical diagnosis techniques involve upper endoscopy, imaging tests and exploratory surgery. Treatment options include surgery, chemotherapy, radiotherapy and targeted therapy.

Global gastric cancer market is conspicuous by poor prognosis, because of the indolent nature of the disease. However, better diagnostic technology and shifting treatment market from chemotherapy to targeted therapies is expected to warrant positive growth in the years ahead. Rising oncology drug spending, ageing population, increasing obese population and rising global male population are expected to drive this growth. Certain trends in the global gastric cancer market include, a healthy pipeline of combinations targeted therapies, shifting focus towards molecular targeted therapies, and keen interest in eradication H. Pylori infection across the globe. The market is however, afflicted by certain challenges like low penetration of new targeted therapies and lack of reimbursement of cancer drugs.

The report provides an overview of the entire market through global and regional analysis. Prevalence and market value of gastric cancer across the globe and that of its various types and stages including advanced, her2 positive, stage III and metastatic gastric cancer have been analyzed.

Complete report available at

Few Points from List of Charts:

Different Types of Gastric Cancer

Global Gastric Cancer Market by Prevalence (2015-2020E)

Global Advanced Gastric Cancer Market by Value (2015-2020E)

The U.S. Gastric Cancer Market by Prevalence (2015-2020E)

Prevalence of Her 2+ Gastric Cancer in the U.S. (2015-2020E)

Prevalence of Stage III Gastric Cancer in the U.S. (2015-2020E)

The U.S. Advanced Gastric Cancer Market by Prevalence (2015-2020E)

The U.S. Advanced Gastric Cancer Market by Value (2015-2020E)

Prevalence of Metastatic Gastric Cancer in the U.S. (2015-2020E)

Prevalence of Her2+ Gastric Cancer in the EU (2015-2020E)

Prevalence of Stage III Gastric Cancer in the EU (2015-2020E)

Prevalence of Metastatic Gastric Cancer in the EU (2015-2020E)

The EU5 Gastric Cancer Market by Prevalence (2015-2020E)

Browse All Latest Pharmaceuticals Market Research Reports at

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune – 411001.
Maharashtra, India.
Tel: + 1 888 391 5441

%d bloggers like this: